Research LettersTreatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders
References (5)
- et al.
Interferon alfa in the treatment of chronic viral hepatitis B and C
Ann Pharmacother
(1997) - et al.
Psychiatric complications of long-term interferon alpha therapy
Arch Intern Med
(1987)
There are more references available in the full text version of this article.
Cited by (164)
Anxiety and depression in patients with hepatitis C infection on interferon treatment: A longitudinal study
2019, Annales Medico-PsychologiquesThe risk of new onset depression in association with influenza - A population-based observational study
2016, Brain, Behavior, and ImmunityCitation Excerpt :Cytokines are part of the cell-to-cell communication in the immune system with pro- or anti-inflammatory properties. Further support of this hypothesis was also provided by clinical observations on patients treated with interferon (IFN) and interleukin-2 (IL-2) who displayed influenza-like symptoms and nonspecific neuropsychiatric symptoms including anorexia, fatigue, altered sleep patterns and pain, with a prevalence ranging from 0% to 45% (Baraldi et al., 2012; Pariante et al., 1999). In most cases, these symptoms could be successfully treated with antidepressants (Khairova et al., 2009).
Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology
2012, Journal of Psychiatric ResearchInflammation in psychopathology of depression: Clinical, biological, and therapeutic implications
2012, BioMedicine (Netherlands)Withdrawing interferon-α from psychiatric patients: Clinical care or unjustifiable stigma?
2013, Psychological Medicine
Copyright © 1999 Elsevier Ltd. All rights reserved.